As­traZeneca changes up asth­ma cam­paign, moves to high­light con­trol for hard-to-con­trol sub­type

As­traZeneca is sun­set­ting Fasen­ra’s qui­et, na­ture-sounds com­mer­cials for new work that aligns its pa­tient and health­care provider au­di­ences for the first time.

The new­ly de­buted …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER